CD8A and neoplasm: Treatment response to immune checkpoint inhibition (CPI) is predicated on antigen-specific CD8+ T cells infiltrating the tumor microenvironment (TME) and elaborating an inflammatory response that includes the secretion of interferon-gamma (IFN-γ)5,6.